Urinary Tract Infection Market Share, Potential Growth, Demand And Analysis Of Key Players- Research Forecasts To 2028

 

Urinary Tract Infection Market

Market Scope

Market Research Future (MRFR)’s newly released study reveals that the urinary tract infection market will expand at a rate of 3.5% from 2020 to 2027. The market valuation by the end of the analysis period will be around USD 11.3 billion, adds the extensive report.

Primary Boosters and Barriers

Rising investments in exhaustive research & development of novel drugs and advanced devices could be a crucial growth inducer of the market growth in the years ahead.  Majority of the companies are focused on carrying out extensive R&D activities for antibiotics. The key firms in the market part of these research studies include Cipla, Pfizer, and GlaxoSmithKline, investing substantially in antibacterial discovery trials.

The Urinary Tract Infection Market size is slated to experience significant upsurge in the coming years, due to the surging burden of UTIs among women in the reproductive age group. A few other risk aspects include the utilization of contraceptive diaphragms, urinary tract abnormalities, and menopause, which are developing rapidly among the female population worldwide. This will be a major reason behind the robust business expansion in the ensuing years.

Striking increase in cases of diabetes and obesity and the consequent development of bladder dysfunction, paired with the surging use of cutting-edge technologies like nanotechnology stimulates the market growth as well.

Top Firms

Allergan, Eli Lily, Company, GlaxoSmithKline plc, Cipla Inc., Pfizer Inc., Novo Nordisk A/S, Bayer AG, Novartis Ag, Teva Pharmaceuticals, Merck & Co. Inc. are identified as the top urinary tract infection drug and products manufacturers highlighted in the extensive study.

Segmental Analysis

Drug class, application, pathogen, and end-user are the segments depending on which the urinary tract infections market has been considered in the review study.

Drug class-based segments outlined in the study are aminoglycosides, quinolones, azoles, along with cephalosporins, and penicillin. Quinolones-wise, the major segments are pefloxacin, enoxacin, fleroxacin, and norfloxacin.

Applications of urinary tract infection drugs and devices are in urethritis, cystitis, pyelonephritis, and others. Urethritis can expect the highest growth in the forthcoming period.

Pathogens studied in the report are Proteus mirabilis, klebsiella pneumonia, escherichia coli, and more.

Market end-users are healthcare centers, hospitals, self-administered kits, and clinics.

Regional Status

North America presides over the worldwide market for urinary tract infections, in terms of revenue generation. The North American market should continue to create waves over the following years, thanks to the soaring cases of diabetes and various chronic disorders. The mushrooming UTI patient base, particularly in the United States further fosters the industry share in the region. Studies have revealed that over 40 million Americas have diabetes, with more than 11% of the population in the US, resulting in higher vulnerability to infections such as UTIs. Vast pool of public health laboratories providing extensive services for UTI testing, paired with the availability of medical insurance are also a few other important growth boosters.

Asia Pacific will be covering considerable grounds at the fastest pace from 2020 to 2027, as the healthcare infrastructure continues to improve and cases of diabetes and UTI cases mounting in India, Malaysia, Singapore, and China. The mounting number of urinary tract infection testing, paired with the stunning expansion of the biopharma and pharma industries could further boost the business value in the region over the years to come. Experts believe that Asia Pacific will be a prime spot for the market, given the tremendous growth of the medical tourism industry across India and Japan. Other growth opportunities in the region will be the rapidly aging populace, surge in consumer awareness, rise in kidney diseases, supportive government policies, and the upgradation of the healthcare infrastructure.

Latest Updates

September 2021

BDR Pharma introduces BIAPENEM, a drug that helps in the treatment of patients with a variety of disorders, including urinary tract infections, intra-abdominal infections, and lower respiratory infections. BDR Pharma is the first company in India to design the drug, conducting clinical trials alongside a few affluent firms that are part of the critical care space. BDR Pharma also managed to receive approval from DCGI (Drug Controller General of India) for this drug, also the first-ever instance in the country.            

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

 

Comments

Post a Comment

Popular posts from this blog

Ayurvedic Products Market Outlook, Trend, Growth and Share Estimation Analysis and Forecast 2020-2030

Image
  Global Ayurvedic Products Market Overview Ayurvedic Products are generally used in personal care and healthcare products. Ayurvedic products originated from India, and thus, the concentration of ayurvedic product suppliers is the highest in the country. According to the latest research reports Due to growing inclination for natural treatment, the Ayurvedic Products Market , size is projected to reach USD 28830.5 Million by 2030 at 12.3% CAGR. Many factors are influencing a significant rise in the growth rate between during forecast periods. Increasing adoption of traditional methods for medicinal purposes is observed to cause a significant boost in the global Ayurvedic Products Market With a rise in the working woman population, rising disposable income, and a growing inclination towards chemical free and herbal cosmetics are some of the primary factors contributing to the ascension of the global ayurvedic market. Apart from personal care, ayurvedic healthcare products are...
Read more

Pain Management Devices Market Set To Exhibit Strong Growth, Valuable Research Factors and Industry Forecast to 2030

Image
  Pain Management Devices Market – Overview The Pain Management Devices Market can anticipate expansion at a rate of 7.12% from 2020 to 2030, believes MRFR (Market Research Future). Progress in technology and better research capabilities have led to the development of devices that can control pain with limited use of drugs. Focused Market reports connected to the healthcare sector among others lately have been made available by Market Research Future which publishes a report on this sector. The development of pain management devices has been useful to control pain in a wide range of ailments. The level of relief from pain that is experienced, is one of the major driving factors for the industry, as patients who use such devices are prone to chronic pain daily. Cancer patients and the geriatric population are among the major user segments for the pain management devices as medication alone may not be sufficient to provide pain relief in their situation. The industry is antici...
Read more

Breast Cancer Market 2022-2027 Worldwide Demand and Growth Analysis Report 2022-2027

Image
  Breast Cancer is the second-most common type of cancer in women and one of the paramount concerns, globally. According to WHO, every year, around 200,000 new cases get registered, and the digits are continuously increasing. Many statistics show that breast cancer is more prevalent in developed countries such as the UK, the US, and Australia as their women are more prone to acquire the disease. This doesn’t mean that women from developing countries like India and China are out of breast cancer’s radar. On the contrary, they are more vulnerable than women from developed regions. Unavailability of proper treatment due to the lack of funds and awareness towards the government’s programs is killing them more than breast cancer can. Advancements in medical science and biotechnology have improved the outlook of diagnosis. However, the recovery is still challenging as survivors adjust to the scars that remain mentally and physically. Surprisingly, the Breast Cancer Market is still a...
Read more